InterStim Therapy was previously approved to treat the symptoms of overactive bladder and non-obstructive urinary retention.
InterStim Therapy uses an implantable system, consisting of a thin wire lead and a neurostimulator, or pacemaker-like device, as well as external clinician and patient programmers.
Data from the Medtronic-sponsored pivotal study that led to FDA approval show InterStim Therapy for Bowel Control reduced fecal incontinent episodes and increased quality of life in patients with the condition.
